Regenerative Medicine

Regenerative Medicine

REGEN MED
影响因子:2.6
JCR分区:Q3
中科院分区:医学 4区
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Future Medicine Ltd.
发刊时间:2006
收录数据库:SCIE/Scopus收录
ISSN:1746-0751

期刊介绍

Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.
再生医学可替换或再生人体细胞、组织或器官,以恢复或建立正常功能*。自2006年以来,再生医学一直处于出版最好的论文和评论的前沿,涵盖了整个再生医学领域。该杂志关注再生医学的整个方法谱,包括小分子药物、生物制剂、生物材料和组织工程,以及细胞和基因治疗-这是所有关于再生,而不是一个特定的平台技术。该杂志的范围涵盖了该领域的所有方面,从发现研究到临床开发,再到商业化。《再生医学》是一份经过同行评审的期刊,致力于发表最好的再生医学研究、临床翻译和商业化,为生物医学科学和医疗保健的重要领域提供独特的支持。《再生医学》提供了一个专家论坛,以解决再生医学的重要挑战和进展,以简洁、清晰和有吸引力的文章格式-对于一个快速发展的,多学科的和日益紧迫的时间社区至关重要。尽管我们的知识和理解再生的实质性发展,该领域仍然处于起步阶段。然而,进展正在加快。在未来几十年里,我们将发现并开发出针对患者的变革性疗法,在某些情况下甚至是治愈。再生医学将继续提供这些进展的关键概述,因为他们的进展,进行临床试验,并最终成为主流医学。

相关文章

年发文量 36
国人发稿量 6.43
国人发文占比 0.18%
自引率 -
平均录取率0
平均审稿周期 较慢,6-12周
版面费 -
偏重研究方向 医学-工程:生物医学
期刊官网 http://www.futuremedicine.com/loi/rme
投稿链接 http://www.futuremedicine.com/page/submitarticle

期刊高被引文献

Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0161
Exploration of 2-deoxy-D-ribose and 17β-Estradiol as alternatives to exogenous VEGF to promote angiogenesis in tissue-engineered constructs.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0068
First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0171
Nomenclature and heterogeneity: consequences for the use of mesenchymal stem cells in regenerative medicine
来源期刊:Regenerative MedicineDOI:10.2217/rme-2018-0145
Evaluating the efficacy of tissue-engineered human amniotic membrane in the treatment of myocardial infarction.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0024
Toward a unified theory of aging and regeneration.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0062
Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0001
Better therapeutic potential of bone marrow-derived mesenchymal stem cells compared with chorionic villi-derived mesenchymal stem cells in airway injury model.
来源期刊:Regenerative medicineDOI:10.2217/RME-2018-0152
Isogenic-induced endothelial cells enhance osteogenic differentiation of mesenchymal stem cells on silk fibroin scaffold.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0166
An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0137
Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0133
Autologous plasma rich in growth factors technology for isolation and ex vivo expansion of human dental pulp stem cells for clinical translation.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0066
Conditioned medium from 3D culture system of stromal vascular fraction cells accelerates wound healing in diabetic rats.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0083
Reliable assessment of bone marrow and bone marrow concentrates using automated hematology analyzer.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0173
Therapeutic targeting of gastrointestinal cancer stem cells.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0146
Use of extracellular matrix hydrogel from human placenta to restore hair-inductive potential of dermal papilla cells.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0112
University of Wisconsin solution for the xeno-free storage of adipose tissue-derived microvascular fragments.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0164
Freeze-dried versus fresh platelet-rich plasma in acute wound healing of an animal model.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0119
Screen-enrich-combine circulating system to prepare MSC/β-TCP for bone repair in fractures with depressed tibial plateau.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0047
Advances in electrical and magnetic stimulation on nerve regeneration.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0079
Polycaprolactone/gelatin degradable vascular grafts simulating endothelium functions modified by nitric oxide generation.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0015
Stem and progenitor cell microenvironment for bone regeneration and repair.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0044
Industry updates from the field of stem cell research and regenerative medicine in July 2019.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0101
Efficiency of mesenchymal stem cells in treatment of urinary incontinence: a systematic review on animal models.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0040
Human umbilical cord blood cells restore vascular integrity in injured rat brain and modulate inflammation in vitro.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0106
Immunogenicity analysis of decellularized cardiac scaffolds after transplantation into rats.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0139
Poly-ε-caprolactone and polyvinyl alcohol electrospun wound dressings: adhesion properties and wound management of skin defects in rabbits.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0072
Investigation mechanisms between normal, developing and regenerating livers for regenerative liver drug design.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0058
Manufacturing MSCs for commercial application: an interview with Ross Macdonald.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0122
Bone tissue engineering in the greater omentum is enhanced by a periosteal transplant in a miniature pig model.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0031
Transplantation efficacy of autologous bone marrow mesenchymal stem cells combined with atorvastatin for acute myocardial infarction (TEAM-AMI): rationale and design of a randomized, double-blind, placebo-controlled, multi-center, Phase II TEAM-AMI trial.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0024
Degradation and in vivo evaluation of polycaprolactone, poly(ε-caprolactone-co-L-lactide), and poly-L-lactic acid as scaffold sealant polymers for murine tissue-engineered vascular grafts.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0069
Preparation and characterization of human size whole heart for organ engineering: scaffold microangiographic imaging.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0111
Bench-to-bedside optimization of mesenchymal stem cell isolation, processing, and expansion for in vivo administration.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0043
Regulations on cell therapy products in China: a brief history and current status.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0069
The management of risk and investment in cell therapy process development: a case study for neurodegenerative disease.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0081
Fetal liver stem cell transplantation for liver diseases.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0160
Intravascular cell therapy in stroke: predicting the future trends.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0037
Industry updates from the field of stem cell research and regenerative medicine in January 2019.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0031
Utilizing platelet-rich fibrin bioscaffold at the graft site improves the structure and function of mice ovarian grafts.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0050
Skin regenerative medicine advancements in the Islamic Republic of Iran: a concise review.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0170
Regenerative effects of mesenchymal stem cells by dosage in a chronic rotator cuff tendon tear in a rabbit model.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0125
Transcribing the heart: faithfully interpreting cardiac transcriptional insights.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0063
Industry updates from the field of stem cell research and regenerative medicine in May 2019.
来源期刊:Regenerative medicineDOI:10.2217/RME-2019-0075
Industry updates from the field of stem cell research and regenerative medicine in June 2019.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0093
Circulatory support and stem cell therapy in the management of advanced heart failure: a concise review of available evidence.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0121
Intravenous administration of multipotent stromal cells and bone allograft modification to enhance allograft healing.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0063
Generation and comprehensive characterization of induced pluripotent stem cells for translational research.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0148
Establishing the variation of blood metrics within UK Biobank to inform cell therapy manufacturing processes.
来源期刊:Regenerative medicineDOI:10.2217/rme-2018-0168
Spondylodiscitis due to Cutibacterium acnes following lumbosacral intradiscal biologic therapy: a case report.
来源期刊:Regenerative medicineDOI:10.2217/rme-2019-0008

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
69.44%26.21%-4.17%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q3区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
CELL & TISSUE ENGINEERING
Q3

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
CELL & TISSUE ENGINEERING 细胞与组织工程
4区
ENGINEERING, BIOMEDICAL 工程:生物医学
4区
2023年12月升级版
医学4区
CELL & TISSUE ENGINEERING 细胞与组织工程
4区
ENGINEERING, BIOMEDICAL 工程:生物医学
4区
2022年12月旧的升级版
工程技术4区
CELL & TISSUE ENGINEERING 细胞与组织工程
4区
ENGINEERING, BIOMEDICAL 工程:生物医学
4区